Group A streptococci clones associated with invasive infections and pharyngitis in Portugal present differences in emm types, superantigen gene content and antimicrobial resistance

BMC Microbiology

Volumn 12, Issue , 2012, Pages

  Friães, Ana ^a   Pinto, Francisco R ^b   Silva Costa, Catarina ^a   Ramirez, Mario ^a   Melo Cristino, José ^a  

^a UNIVERSITY OF LISBON   (Portugal)

^b UNIVERSITY OF LISBON   (Portugal)

Author keywords

Exotoxins; Invasive infection; Pharyngitis; Streptococcal M protein; Streptococcus pyogenes

Indexed keywords

BACITRACIN; CHLORAMPHENICOL; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; LEVOFLOXACIN; LINEZOLID; MACROLIDE; PENICILLIN DERIVATIVE; SUPERANTIGEN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CHILD; CLONE; EMM GENE; EMM4 GENE; EMM75 GENE; GENE CLUSTER; GENE INTERACTION; GROUP A STREPTOCOCCAL INFECTION; HUMAN; NONHUMAN; PORTUGAL; PULSED FIELD GEL ELECTROPHORESIS; SPEA GENE; SPEJ GENE; SPEL GENE; SPEM GENE; SSA GENE; STREPTOCOCCAL PHARYNGITIS; STREPTOCOCCUS GROUP A;

ADOLESCENT; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; PHARYNGITIS; PORTUGAL; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; SUPERANTIGENS;

BACTERIA (MICROORGANISMS); SPEA; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SP. 'GROUP A';

EID: 84872274958     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-12-280     Document Type: Article

References (45)

1. Pathogenesis of group A streptococcal infections. Cunningham MW, Clin Microbiol Rev 2000 13 470 511 10.1128/CMR.13.3.470-511.2000 10885988 (Pubitemid 30452618)
2. Group A streptococci in the 1990s. Efstratiou A, J Antimicrob Chemother 2000 45 3 12 10.1093/jac/45.suppl-1.3 10759357 (Pubitemid 30093616)
3. The global burden of group A streptococcal diseases. Carapetis JR, Steer AC, Mulholland EK, Weber M, Lancet Infect Dis 2005 5 685 694 10.1016/S1473-3099(05)70267-X 16253886 (Pubitemid 41505357)
4. Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. Luca-Harari B, Darenberg J, Neal S, Siljander T, Strakova L, Tanna A, Creti R, Ekelund K, Koliou M, Tassios PT, van der Linden M, Straut M, Vuopio-Varkila J, Bouvet A, Efstratiou A, Schalén C, Henriques-Normark B, Jasir A, J Clin Microbiol 2009 47 1155 1165 10.1128/JCM.02155-08 19158266
5. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. O'Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A, Albanese BA, Farley MM, Barrett NL, Spina NL, Beall B, Harrison LH, Reingold A, Van Beneden C, Clin Infect Dis 2007 45 853 862 10.1086/521264 17806049 (Pubitemid 47580376)
6. Association of group A streptococcal emm types with virulence traits and macrolide-resistance genes is independent of the source of isolation. Creti R, Gherardi G, Imperi M, von Hunolstein C, Baldassarri L, Pataracchia M, Alfarone G, Cardona F, Dicuonzo G, Orefici G, J Med Microbiol 2005 54 913 917 10.1099/jmm.0.46035-0 16157543 (Pubitemid 41395846)
7. Variations in emm type among group A streptococcal isolates causing invasive or noninvasive infections in a nationwide study. Ekelund K, Darenberg J, Norrby-Teglund A, Hoffmann S, Bang D, Skinhøj P, Konradsen HB, J Clin Microbiol 2005 43 3101 3109 10.1128/JCM.43.7.3101-3109.2005 16000420 (Pubitemid 40981308)
8. Epidemiological and molecular analysis of Streptococcus pyogenes isolates causing invasive disease in Spain (1998-2009): comparison with non-invasive isolates. Montes M, Ardanuy C, Tamayo E, Domènech A, Liñares J, Pérez-Trallero E, Eur J Clin Microbiol Infect Dis 2011 30 1295 1302 10.1007/s10096-011-1226-x 21491178
9. Distribution of emm type and antibiotic susceptibility of group A streptococci causing invasive and noninvasive disease. Wajima T, Murayama SY, Sunaoshi K, Nakayama E, Sunakawa K, Ubukata K, J Med Microbiol 2008 57 1383 1388 10.1099/jmm.0.2008/002642-0 18927416
10. Molecular characterisation of group A streptococci from invasive and non-invasive disease episodes in Belgium during 1993-1994. Descheemaeker P, Van Loock F, Hauchecorne M, Vandamme P, Goossens H, J Med Microbiol 2000 49 467 471 10798560 (Pubitemid 30261412)
11. Superantigen gene profile, emm type and antibiotic resistance genes among group A streptococcal isolates from Barcelona, Spain. Rivera A, Rebollo M, Miró E, Mateo M, Navarro F, Gurguí M, Mirelis B, Coll P, J Med Microbiol 2006 55 1115 1123 10.1099/jmm.0.46481-0 16849733 (Pubitemid 44215571)
12. Strain prevalence, rather than innate virulence potential, is the major factor responsible for an increase in serious group A streptococcus infections. Rogers S, Commons R, Danchin MH, Selvaraj G, Kelpie L, Curtis N, Robins-Browne R, Carapetis JR, J Infect Dis 2007 195 1625 1633 10.1086/513875 17471432 (Pubitemid 46799220)
13. Illustration of a common framework for relating multiple typing methods by application to macrolide-resistant Streptococcus pyogenes. Carriço JA, Silva-Costa C, Melo-Cristino J, Pinto FR, de Lencastre H, Almeida JS, Ramirez M, J Clin Microbiol 2006 44 2524 2532 10.1128/JCM.02536-05 16825375 (Pubitemid 44092422)
14. Streptococcus pyogenes: Insight into the function of the streptococcal superantigens. Sriskandan S, Faulkner L, Hopkins P, Int J Biochem Cell Biol 2007 39 12 19 10.1016/j.biocel.2006.08.009 17029999 (Pubitemid 44548448)
15. Toxin-gene profile heterogeneity among endemic invasive European group A streptococcal isolates. Schmitz F-J, Beyer A, Charpentier E, Normark BH, Schade M, Fluit AC, Hafner D, Novak R, J Infect Dis 2003 188 1578 1586 10.1086/379230 14624385 (Pubitemid 37523945)
16. Superantigen genes are more important than the emm type for the invasiveness of group A Streptococcus infection. Lintges M, van der Linden M, Hilgers R-D, Arlt S, Al-Lahham A, Reinert RR, Plücken S, Rink L, J Infect Dis 2010 202 20 28 10.1086/653082 20497047
17. Nonoutbreak surveillance of group A streptococci causing invasive disease in Portugal identified internationally disseminated clones among members of a genetically heterogeneous population. Friães A, Ramirez M, Melo-Cristino J, the Portuguese Group for the Study of Streptococcal Infections, J Clin Microbiol 2007 45 2044 2047 10.1128/JCM.00496-07 17460058 (Pubitemid 46933958)
18. Superantigen gene complement of Streptococcus pyogenes-relationship with other typing methods and short-term stability. Friães A, Pinto FR, Silva-Costa C, Ramirez M, Melo-Cristino J, Eur J Clin Microbiol Infect Dis 2012 In press. (http://dx.doi.org/10.1007/s10096-012-1726-3)
19. An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. Cockerill FR, MacDonald KL, Thompson RL, Roberson F, Kohner PC, Besser-Wiek J, Manahan JM, Musser JM, Schlievert PM, Talbot J, Frankfort B, Steckelberg JM, Wilson WR, Osterholm MT, JAMA 1997 277 38 43 10.1001/jama.1997.03540250046030 8980208 (Pubitemid 27009039)
20. A genetic-based evaluation of the principal tissue reservoir for group A streptococci isolated from normally sterile sites. Fiorentino TR, Beall B, Mshar P, Bessen DE, J Infect Dis 1997 176 177 182 10.1086/514020 9207364 (Pubitemid 27272866)
21. Tetracycline resistance in group A streptococci: emergence on a global scale and influence on multiple-drug resistance. Ayer V, Tewodros W, Manoharan A, Skariah S, Luo F, Bessen DE, Antimicrob Agents Chemother 2007 51 1865 1868 10.1128/AAC.01341-06 17307980 (Pubitemid 46744176)
22. Tetracycline and macrolide co-resistance in Streptococcus pyogenes: co-selection as a reason for increase in macrolide-resistant S. pyogenes? Nielsen HUK, Hammerum AM, Ekelund K, Bang D, Pallesen LV, Frimodt-Møller N, Microb Drug Resist 2004 10 231 238 15383167 (Pubitemid 39281724)
23. Bacitracin-resistant clone of Streptococcus pyogenes isolated from pharyngitis patients in Belgium. Malhotra-Kumar S, Wang S, Lammens C, Chapelle S, Goossens H, J Clin Microbiol 2003 41 5282 5284 10.1128/JCM.41.11.5282-5284. 2003 14605184 (Pubitemid 37429961)
24. Clonal spread of emm type 28 isolates of Streptococcus pyogenes that are multiresistant to antibiotics. Mihaila-Amrouche L, Bouvet A, Loubinoux J, J Clin Microbiol 2004 42 3844 3846 10.1128/JCM.42.8.3844-3846.2004 15297545 (Pubitemid 39045727)
25. Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of northern California. York MK, Gibbs L, Perdreau-Remington F, Brooks GF, J Clin Microbiol 1999 37 1727 1731 10325315 (Pubitemid 29235214)
26. Resistance to bacitracin in Streptococcus pyogenes from oropharyngeal colonization and noninvasive infections in Portugal was caused by two clones of distinct virulence genotypes. Pires R, Rolo D, Mato R, Feio de Almeida J, Johansson C, Henriques-Normark B, Morais A, Brito-Avô A, Gonçalo-Marques J, Santos-Sanches I, FEMS Microbiol Lett 2009 296 235 240 10.1111/j.1574-6968.2009.01642.x 19486163
27. Identification of macrolide-resistant clones of Streptococcus pyogenes in Portugal. Silva-Costa C, Ramirez M, Melo-Cristino J, Clin Microbiol Infect 2006 12 513 518 10.1111/j.1469-0691.2006.01408.x 16700698 (Pubitemid 43740762)
28. Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Darenberg J, Luca-Harari B, Jasir A, Sandgren A, Pettersson H, Schalén C, Norgren M, Romanus V, Norrby-Teglund A, Normark BH, Clin Infect Dis 2007 45 450 458 10.1086/519936 17638193 (Pubitemid 47204461)
29. Superantigens and streptococcal toxic shock syndrome. Proft T, Sriskandan S, Yang L, Fraser JD, Emerging Infect Dis 2003 9 1211 1218 10.3201/eid0910. 030042 14609454 (Pubitemid 37210560)
30. The heterogeneity of endemic community pediatric group A streptococcal pharyngeal isolates and their relationship to invasive isolates. Haukness HA, Tanz RR, Thomson RB, Pierry DK, Kaplan EL, Beall B, Johnson D, Hoe NP, Musser JM, Shulman ST, J Infect Dis 2002 185 915 920 10.1086/339407 11920315 (Pubitemid 34274434)
31. Mosaic prophages with horizontally acquired genes account for the emergence and diversification of the globally disseminated M1T1 clone of Streptococcus pyogenes. Aziz RK, Edwards RA, Taylor WW, Low DE, McGeer A, Kotb M, J Bacteriol 2005 187 3311 3318 10.1128/JB.187.10.3311-3318.2005 15866915 (Pubitemid 40628684)
32. Evolutionary origin and emergence of a highly successful clone of serotype M1 group A Streptococcus involved multiple horizontal gene transfer events. Sumby P, Porcella SF, Madrigal AG, Barbian KD, Virtaneva K, Ricklefs SM, Sturdevant DE, Graham MR, Vuopio-Varkila J, Hoe NP, Musser JM, J Infect Dis 2005 192 771 782 10.1086/432514 16088826 (Pubitemid 41193074)
33. Streptococcus pyogenes emm and T types within a decade, 1996-2005: implications for epidemiology and future vaccines. Nir-Paz R, Korenman Z, Ron M, Michael-Gayego A, Cohen-Poradosu R, Valinsky L, Beall B, Moses AE, Epidemiol Infect 2010 138 53 60 10.1017/S0950268809002805 19480723
34. Group A streptococci from invasive-disease episodes in Poland are remarkably divergent at the molecular level. Szczypa K, Sadowy E, Izdebski R, Strakova L, Hryniewicz W, J Clin Microbiol 2006 44 3975 3979 10.1128/JCM.01163-06 16957033 (Pubitemid 44737238)
35. Highly frequent mutations in negative regulators of multiple virulence genes in group A streptococcal toxic shock syndrome isolates. Ikebe T, Ato M, Matsumura T, Hasegawa H, Sata T, Kobayashi K, Watanabe H, PLoS Pathog 2010 6 1000832 10.1371/journal.ppat.1000832 20368967
36. An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Kotb M, Norrby-Teglund A, McGeer A, El-Sherbini H, Dorak MT, Khurshid A, Green K, Peeples J, Wade J, Thomson G, Schwartz B, Low DE, Nat Med 2002 8 1398 1404 10.1038/nm1202-800 12436116 (Pubitemid 36019425)
37. Decrease in macrolide resistance and clonal instability among Streptococcus pyogenes in Portugal. Silva-Costa C, Pinto FR, Ramirez M, Melo-Cristino J, Portuguese Suveillance Group for the Study of Respiratory Pathogens, Clin Microbiol Infect 2008 14 1152 1159 10.1111/j.1469-0691.2008. 02104.x 19046174
38. Streptococcus pyogenes isolated in Portugal: macrolide resistance phenotypes and correlation with T types. Melo-Cristino J, Fernandes ML, Portuguese Surveillance Group for the Study of Respiratory Pathogens, Microb Drug Resist 1999 5 219 225 10.1089/mdr.1999.5.219 10566873 (Pubitemid 29519900)
39. Centers for Disease Control and Prevention-CDC Streptococcus Laboratory, [ http://www.cdc.gov/ncidod/biotech/strep/strepindex.htm ]
40. Streptococcus agalactiae in a large Portuguese teaching hospital: antimicrobial susceptibility, serotype distribution, and clonal analysis of macrolide-resistant isolates. Figueira-Coelho J, Ramirez M, Salgado MJ, Melo-Cristino J, Microb Drug Resist 2004 10 31 36 10.1089/107662904323047772 15140391 (Pubitemid 38529714)
41. Expression of resistance to tetracyclines in strains of methicillin-resistant Staphylococcus aureus. Trzcinski K, Cooper BS, Hryniewicz W, Dowson CG, J Antimicrob Chemother 2000 45 763 770 10.1093/jac/45.6.763 10837427 (Pubitemid 30348944)
42. Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone. Enright MC, Spratt BG, Kalia A, Cross JH, Bessen DE, Infect Immun 2001 69 2416 2427 10.1128/IAI.69.4.2416-2427.2001 11254602 (Pubitemid 32239712)
43. MLST-Multilocus Sequence Typing-Streptococcus pyogenes [ http://spyogenes.mlst.net/ ]
44. PHYLOViZ: Phylogenetic inference and data visualization for sequence based typing methods. Francisco AP, Vaz C, Monteiro PT, Melo-Cristino J, Ramirez M, Carriço JA, BMC Bioinforma 2012 13 87 10.1186/1471-2105-13-87
45. Controlling the false discovery rate-a practical and powerful approch to multiple testing. Benjamini Y, Hochberg Y, J R Stat Soc Ser B Statistical Methodology 1995 57 289 300